A simple method for in vitro preparation of natural killer cells from cord blood

BMC Biotechnol. 2019 Nov 21;19(1):80. doi: 10.1186/s12896-019-0564-0.

Abstract

Background: Cord Blood (CB) has been considered a promising source of natural killer (NK) cells for cellular immunotherapy. However, it is difficult to expand the large numbers of highly pure NK cells from CB without cell sorting and feeder cells/multiple cytokines. In this study, we try to develop a simple, safe and economical method for ex vivo expansion and purification of NK cells from CB without cell sorting and feeder cells/multiple cytokines.

Results: The large numbers (mean: 1.59 × 1010) of highly pure (≥90%) NK cells from CB could be obtained through interleukin-2, group A streptococcus and zoledronate stimulation of mononuclear cells using the 21-day culture approach. When compared to resting NK cells, expanded NK cells were a higher expression of activating receptors CD16, NKG2D, NKp30, NKp44, NKp46 and activating markers CD62L and CD69, while the inhibitory receptors, CD158a and CD158b remained largely unchanged. In addition, these cells showed a higher concentration of IFN-γ, TNF-α and GM-CSF secretion and cytotoxicity to K562 cells and acute myeloid leukemia targets than resting NK cells.

Conclusion: We develop a simple, safe and economical method to obtain high yield, purity, and functionality NK cells from CB without cell sorting and feeder cells/multiple cytokines.

Keywords: Cord blood; Cytotoxicity; Expansion; Immunotherapy; Natural killer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Fetal Blood / cytology*
  • Flow Cytometry
  • Humans
  • Immunotherapy / methods*
  • Interleukin-2 / metabolism
  • K562 Cells
  • Killer Cells, Natural / cytology*
  • Leukocytes, Mononuclear / drug effects
  • Zoledronic Acid / pharmacology

Substances

  • Interleukin-2
  • Zoledronic Acid